Jorge Diaz, MD
Clinical Cardiac Electrophysiology · Lake Mary, FLNPI 1487663373
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $112,750 of the $158,477 with a category attached, or 71.1%. Abbott accounts for 96.3% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $51,208, 2.0 times the $25,129 reported in 2019. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 732 payments — averaging $216.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$153K
- Medtronic$3K
- Boston Scientific$2K
- Biosense Webster, Inc.$296
- Biotronik Inc.$288
- Impulse Dynamics (USA) Inc.$151
- plus $388 from 9 others
Across 45 payments — averaging $1036.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$29K
- Boston Scientific$17K
What the payments were for
- Consulting fees$112,75071%
- Speaking & faculty fees$3,7242%
- Travel & lodging$21,83814%
- Food & beverage$20,16513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 610 | $152,681 |
| Medtronic(2 entities) | 65 | $2,517 |
| Boston Scientific | 28 | $2,156 |
| Biosense Webster, Inc. | 4 | $296 |
| Biotronik Inc. | 8 | $288 |
| Impulse Dynamics (USA) Inc. | 1 | $151 |
| Amgen | 2 | $123 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $36 |
| Cardiva Medical, Inc. | 2 | $33 |
| Cordis US CORP. | 1 | $26 |
| Novartis | 1 | $23 |
| ZOLL Respicardia, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Acutus Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$44,506
- AMPLATZER AMULET$29,519
- Ensite Cardiac Mapping System$21,627
- JETi All In One Non-Sterile Kit$14,875
- Advisor Catheter$6,615
- ACCENT$5,338
- GALLANT$4,188
- ADVISOR$3,706
- EnSite Precision Cardiac Mapping System$2,309
- ENSITE PRECISION$2,157
- ENSITE$1,901
- Allure CRT Pacemaker$1,810
- Assurity Pacemaker$1,556
- RHYTHMIA$1,184
- Quadra Assura CRT Defibrillator$889
- Unify Assura CRT Defibrillator$717
- Cardiovascular- Research only$710
- ALLURE$638
- Fortify Assura, Ellipse ICD$550
- ABSOLUTE PRO$359
How this compares
$158,477 in reported general payments places this provider in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 118 | $139,691 |
| EntrestoSacubitril/Valsartan | 18 | $20,890 |
| XareltoRivaroxaban | 13 | $14,333 |
| Amiodarone Hcl | 90 | $3,500 |
| SotalolSotalol Hcl | 132 | $2,917 |
| Metoprolol Succinate | 157 | $2,042 |
| Dofetilide | 30 | $1,920 |
| ClopidogrelClopidogrel Bisulfate | 103 | $904 |
| Metoprolol Tartrate | 105 | $833 |
| Flecainide Acetate | 27 | $481 |
| Sucralfate | 14 | $366 |
| Minocycline Hcl | 36 | $334 |
| Pantoprazole Sodium | 53 | $322 |
| Carvedilol | 42 | $290 |
| Valsartan | 18 | $233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $23 | $20,89018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Lake Mary
- Mohamed ElshazlyLake Mary$52K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.